Neoadjuvant ICI Without Chemotherapy Demonstrates Potential Efficacy in Patients with Early-Stage TNBC By Ogkologos - November 21, 2024 1033 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the BELLINI study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate ESMO and ASCO publish joint consensus statement on streamlining clinical research FDA Grants Accelerated Approval to Camizestrant with a CDK4/6 Inhibitor for ESR1-Mutated HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer MOST POPULAR See How These Food Banks Are Putting Your Feed Thy Neighbor... February 9, 2021 Greater OS Benefit Among Patients with Advanced Cancer Treated with Matched... November 11, 2024 More Treatment Options Emerging for Some Men with Metastatic Prostate Cancer June 19, 2019 Happy New Year From Our Team January 4, 2021 Load more HOT NEWS News digest – cancer blood test, gum disease and junk food... Researchers at Purdue Create Filler That May Help Regenerate Tissue in... EMA Recommends Extension of Indications for Sugemalimab Vax-On Points to Maintenance of Active Anticancer Treatment Throughout the Whole...